BAK antibody | knockout validation | Cell Signaling 12105

This is a knockout-validated antibody summary, based on two publication "Mito-priming as a method to engineer Bcl-2 addiction" (Figure 1, discussed below) [1], and "Mitochondrial permeabilization engages NF-κB-dependent anti-tumour activity under caspase deficiency" (See supplement figure 1i in [2] ). Labome curates formal publications to compile a list of antibodies with unambiguous specificity within Validated Antibody Database (VAD).

BAK antibody | knockout validation | Cell Signaling 12105 figure 1
Figure 1. Western blot analysis of BAK and BAX expression in CRISPR/CAS9 genome edited cell lines. Actin was probed as a loading control. From [1].
Antibody information

Rabbit monoclonal IgG

Company: Cell Signaling

Antibody: BAK

Catalog number: 12105

Summary: Rabbit monoclonal IgG against a synthetic peptide corresponding to residues surrounding Gly75 of human Bak protein. Reacts with human, mouse, rat, and monkey. Suitable for western blot, immunoprecipitation, immunohistochemistry (paraffin), immunofluorescence/immunocytochemistry and flow cytometry.

Validation Method

Western blot

Sample

Control, BAX-KO, BAK-KO and BAX/BAK-DKO SVEC cells stably expressing tBID-, BIM- or PUMA 2A GFP-BCL-xL.

Primary incubation

1:1,000 dilution.

References
  1. Lopez J, Bessou M, Riley J, Giampazolias E, Todt F, Rochegüe T, et al. Mito-priming as a method to engineer Bcl-2 addiction. Nat Commun. 2016;7:10538 pubmed publisher
  2. Giampazolias E, Zunino B, Dhayade S, Bock F, Cloix C, Cao K, et al. Mitochondrial permeabilization engages NF-κB-dependent anti-tumour activity under caspase deficiency. Nat Cell Biol. 2017;19:1116-1129 pubmed publisher